Review
Published on 26 May 2022
Smart Nanoparticles for Breast Cancer Treatment Based on the Tumor Microenvironment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.907684
- 2,495 views
- 10 citations
Type at least 3 characters
940 articles
Articles
Original Research
Published on 23 May 2022
In Vitro Cell Density Determines the Sensitivity of Hepatocarcinoma Cells to Ascorbate
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.843742
- 1,585 views
- 1 citation
Brief Research Report
Published on 23 May 2022
The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.863329
- 2,615 views
- 9 citations
Original Research
Published on 23 May 2022
Sensitization of Non-Small Cell Lung Cancer Cells to Gefitinib and Reversal of Epithelial–Mesenchymal Transition by Aloe-Emodin Via PI3K/Akt/TWIS1 Signal Blockage
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.908031
- 2,154 views
- 7 citations
Original Research
Published on 20 May 2022
Lumiflavin Reduces Cisplatin Resistance in Cancer Stem-Like Cells of OVCAR-3 Cell Line by Inducing Differentiation
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.859275
- 1,933 views
- 1 citation
Original Research
Published on 20 May 2022
Low Vitamin D Status Predicts Poor Clinical Outcome in Advanced Melanoma Treated With Immune Checkpoint or BRAF/MEK Inhibitors: A Prospective Non-Interventional Side-by-Side Analysis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.839816
- 1,556 views
- 6 citations
Hypothesis and Theory
Published on 19 May 2022
A Theoretical Study on the Medicinal Properties and Eletronic Structures of Platinum(IV) Anticancer Agents With Cl Substituents
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.860159
- 968 views
Review
Published on 19 May 2022
Resistance Mechanisms of the Metastatic Tumor Microenvironment to Anti-Angiogenic Therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.897927
- 1,186 views
- 4 citations
Original Research
Published on 18 May 2022
Solasonine Causes Redox Imbalance and Mitochondrial Oxidative Stress of Ferroptosis in Lung Adenocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.874900
- 2,585 views
- 7 citations
Original Research
Published on 18 May 2022
Long Noncoding RNA HAGLROS Promotes the Malignant Progression of Bladder Cancer by Regulating the miR-330-5p/SPRR1B Axis
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.876090
- 1,828 views
- 2 citations
Editorial
Published on 16 May 2022
Editorial: Risks and Benefits of Adjuvants to Cancer Therapies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.913626
- 2,431 views
Original Research
Published on 13 May 2022
DHW-221, a Dual PI3K/mTOR Inhibitor, Overcomes Multidrug Resistance by Targeting P-Glycoprotein (P-gp/ABCB1) and Akt-Mediated FOXO3a Nuclear Translocation in Non-small Cell Lung Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.873649
- 3,006 views
- 7 citations
Original Research
Published on 13 May 2022
Reclassification of Hepatocellular Cancer With Neural-Related Genes
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.877657
- 2,780 views
- 4 citations
Original Research
Published on 12 May 2022
Arsenic Trioxide Therapy During Pregnancy: ATO and Its Metabolites in Maternal Blood and Amniotic Fluid of Acute Promyelocytic Leukemia Patients
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.887026
- 1,554 views
- 2 citations
Original Research
Published on 12 May 2022
Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of Sanguisorba officinalis Against Colorectal Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.807718
- 2,720 views
- 3 citations
Original Research
Published on 12 May 2022
Comprehensive Analysis of Sterol O-Acyltransferase 1 as a Prognostic Biomarker and Its Association With Immune Infiltration in Glioma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2022.896433
- 2,634 views
- 5 citations